Citation: | Please cite this article as: Hannan EL, Wu YF, Cozzens K, Tamis-Holl J, Ling FSK, Jacobs AK, Venditti FJ, Berger PB, Walford G, King, III SB. Hybrid coronary revascularization vs . percutaneous coronary interventions for multivessel coronary artery disease. J Geriatr Cardiol 2021; 18(3): 159−167. DOI: 10.11909/j.issn.1671-5411.2021.03.003 |
[1] |
Park SJ, Ahn JM, Kim YH, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 2015; 372: 1204−1212. doi: 10.1056/NEJMoa1415447
|
[2] |
Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375−2384. doi: 10.1056/NEJMoa1211585
|
[3] |
Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J 2014; 35: 2821−2830. doi: 10.1093/eurheartj/ehu213
|
[4] |
Gaudino M, Hameed I, Farkouh ME, et al. Overall and cause-specific mortality in randomized clinical trials comparing percutaneous coronary interventions with coronary bypass surgery: A meta-analysis. JAMA Intern Med 2020: e204748.
|
[5] |
Cavalcante R, Sotomi Y, Zeng Y, et al. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery. Heart 2017; 103: 428−433. doi: 10.1136/heartjnl-2016-309720
|
[6] |
Boylan MJ, Lytle BW, Loop FD, et al. Surgical treatment of isolated left anterior descending coronary stenosis: Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg 1994; 107: 657−662. doi: 10.1016/S0022-5223(94)70320-5
|
[7] |
Hannan EL, Racz M, Holmes DR, et al. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents. Circulation 2008; 117: 2071−2078. doi: 10.1161/CIRCULATIONAHA.107.725531
|
[8] |
de Cannière D, Jansens JL, Goldschmidt-Clermont P, et al. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with “on-pump” double bypass grafting. Am Heart J 2001; 142: 563−570. doi: 10.1067/mhj.2001.118466
|
[9] |
Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 2008; 135: 367−375. doi: 10.1016/j.jtcvs.2007.09.025
|
[10] |
Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass graft and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: three-year follow-up results from a single institution. J Am Coll Cardiol 2013; 61: 2525−2533. doi: 10.1016/j.jacc.2013.04.007
|
[11] |
Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg 2018; 156: 1799−1807. doi: 10.1016/j.jtcvs.2018.04.078
|
[12] |
Halkos ME, Liberman HA, Devireddy C, et al. Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery. J Thorac Cardiovasc Surg 2014; 147: 179−185. doi: 10.1016/j.jtcvs.2013.09.010
|
[13] |
Rosenblum JM, Harskamp RE, Hoedemaker N, et al. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thor Cardiovasc Surg 2016; 151: 1081−1089. doi: 10.1016/j.jtcvs.2015.10.061
|
[14] |
Adams C, Burns DJ, Chu MW, Jones PM, Shridar K, Teefy P, et al. Single-stage hybrid coronary revascularization with long-term follow-up. Eur J Cardiothorac Surg 2014; 45: 438−442. doi: 10.1093/ejcts/ezt390
|
[15] |
Harskamp RE, Vassiliades TA, Mehta RH, et al. Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting. J Am Coll Surg 2015; 221: 326−334. doi: 10.1016/j.jamcollsurg.2015.03.012
|
[16] |
Xia Y, Katz AN, Forest SJ, et al. Hybrid coronary revascularization has improved short-term outcomes but worse mid-term reintervention rates compared to CABG: a propensity-matched analysis. Innovations (Phila) 2017; 12: 174−179. doi: 10.1097/imi.0000000000000376
|
[17] |
Giambruno V, Hafiz A, Fox SA, et al. Is the future of coronary arterial revascularization a hybrid approach? The Canadian experience across three centers. Innovations (Phila) 2017; 12: 82−86. doi: 10.1097/imi.0000000000000355
|
[18] |
Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease. J Am Coll Cardiol Interv 2018; 11: 847−852. doi: 10.1016/j.jcin.2018.01.271
|
[19] |
Gasior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. J Am Coll Cardiol Interv 2014; 7: 1277−1284. doi: 10.1016/j.jcin.2014.05.025
|
[20] |
Harskamp RE, Brennan JM, Xian Y, et al. Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the Society of Thoracic Surgeons adult cardiac database. Circulation 2014; 130: 872−879. doi: 10.1161/CIRCULATIONAHA.114.009479
|
[21] |
Harskamp RE, Bagai A, Halkos ME, et al. Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. Am Heart J 2014; 167: 585−592. doi: 10.1016/j.ahj.2014.01.006
|
[22] |
Zhu P, Zhou P, Sun Y, et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis. J Cardiothorac Surg 2015; 10: 63. doi: 10.1186/s13019-015-0262-5
|
[23] |
Hu FB, Cui LQ. Short-term clinical outcomes after hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of multivessel or left main coronary artery disease: a meta-analysis. Coron Artery Dis 2015; 26: 526−534. doi: 10.1097/MCA.0000000000000265
|
[24] |
Phan K, Wong S, Wang N, et al. Hybrid coronary revascularization versus coronary artery bypass surgery: systematic review and meta-analysis. Int J Cardiol 2015; 179: 484−488. doi: 10.1016/j.ijcard.2014.11.061
|
[25] |
Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study. J Am Coll Cardiol 2016; 68: 356−365. doi: 10.1016/j.jacc.2016.05.032
|
[26] |
Lowenstern A, Wu J, Bradley SM, et al. Current landscape of hybrid revascularization: A report from the NCRD CathPCI Registry. Am Heart J 2019; 215: 167−177. doi: 10.1016/j.ahj.2019.06.014
|
[27] |
Ghali WA, Quan H, Brant R, et al. Comparison of two methods of calculating adjusted survival curves from proportional hazards models. JAMA 2001; 286: 1494−1497. doi: 10.1001/jama.286.12.1494
|
[28] |
Diegeler A, Thiele H, Falk V, et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 2002; 347: 561−566. doi: 10.1056/NEJMoa013563
|
[29] |
Loop FD. Internal-thoracic artery grafts: biologically better coronary arteries. N Engl J Med 1996; 334: 263−265. doi: 10.1056/NEJM199601253340411
|
[30] |
Hannan EL, Racz MJ, McCallister BD, et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999; 33: 63−72. doi: 10.1016/S0735-1097(98)00540-3
|